We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+33.75%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$620M
AUM Growth
+$142M
Cap. Flow
+$14M
Cap. Flow %
2.26%
Top 10 Hldgs %
18.29%
Holding
190
New
37
Increased
53
Reduced
62
Closed
17

Top Sells

Rank Stock Value
1
CPK icon
Chesapeake Utilities
CPK
+$6.77M
2
UNF icon
Unifirst Corp
UNF
+$6.04M
3
SWX icon
Southwest Gas
SWX
+$5.04M
4
ICFI icon
ICF International
ICFI
+$4.83M
5
NOMD icon
Nomad Foods
NOMD
+$4.56M

Sector Composition

Rank Sector Weight
1 Financials 21.75%
2 Technology 19.35%
3 Industrials 15.6%
4 Healthcare 13.39%
5 Consumer Discretionary 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRR
76
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$3.82M 0.62%
+123,639
New +$3.13M
QLYS icon
77
Qualys
QLYS
$6.35B
$3.75M 0.61%
30,802
-586
-2% -$58K
RARE icon
78
Ultragenyx Pharmaceutical
RARE
$2.55B
$3.56M 0.57%
25,732
+60
+0.2% +$7.12K
AXSM icon
79
Axsome Therapeutics
AXSM
$10.9B
$3.55M 0.57%
43,613
-75
-0.2% -$5.61K
DCPH
80
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3.54M 0.57%
62,065
+56
+0.1% +$3.32K
SYNA icon
81
Synaptics
SYNA
$4.15B
$2.96M 0.48%
30,675
+4,447
+17% +$362K
IBP icon
82
Installed Building Products
IBP
$6.49B
$2.95M 0.48%
28,947
-18,746
-39% -$1.91M
FIX icon
83
Comfort Systems
FIX
$59.6B
$2.85M 0.46%
54,046
+43
+0.1% +$2.23K
SSD icon
84
Simpson Manufacturing
SSD
$8.16B
$2.76M 0.45%
+29,550
New +$2.74M
ARRY icon
85
Array Technologies
ARRY
$855M
$2.67M 0.43%
+61,857
New +$2.49M
VIVO
86
DELISTED
Meridian Bioscience Inc
VIVO
$2.54M 0.41%
135,871
-779
-0.6% -$14.5K
NVAX icon
87
Novavax
NVAX
$1.31B
$2.46M 0.4%
22,045
-16
-0.1% -$1.7K
CCXI
88
DELISTED
ChemoCentryx, Inc.
CCXI
$2.18M 0.35%
35,160
+14,661
+72% +$839K
DRNA
89
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.12M 0.34%
96,018
+47
+0% +$1.03K
EBS icon
90
Emergent Biosolutions
EBS
$248M
$2.09M 0.34%
23,298
-398
-2% -$36.5K
KYNB
91
Kyntra Bio
KYNB
$29.4M
$2.06M 0.33%
2,223
+2
+0.1% +$2.1K
KRTX
92
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.97M 0.32%
19,407
-11,563
-37% -$1.07M
WKHS icon
93
Workhorse Group
WKHS
$36.3M
$1.97M 0.32%
33
-16
-33% -$1.04M
IGMS
94
DELISTED
IGM Biosciences
IGMS
$1.93M 0.31%
21,900
-15,837
-42% -$1.11M
AB icon
95
AllianceBernstein
AB
$3.47B
$1.9M 0.31%
56,217
SYF icon
96
Synchrony
SYF
$25.6B
$1.75M 0.28%
50,551
ESPR
97
DELISTED
Esperion Therapeutics
ESPR
$1.62M 0.26%
62,245
-38,854
-38% -$1.16M
NKTX icon
98
Nkarta
NKTX
$172M
$1.61M 0.26%
+26,198
New +$1.09M
LAZ icon
99
Lazard
LAZ
$4.31B
$1.57M 0.25%
37,063
ZYME icon
100
Zymeworks
ZYME
$1.67B
$1.55M 0.25%
32,824

Similar funds

Moody Aldrich Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Moody Aldrich Partners held 190 positions worth $620M, up 30% from $478M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Moody Aldrich Partners's Q4 2020 filing shows 37 new, 53 increased, 62 reduced and 17 closed positions. Its largest new stake was CryoPort: 170,714 shares worth $7.49M. The largest sale was Chesapeake Utilities, an estimated $6.77M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Moody Aldrich Partners's largest Q4 2020 buy was CryoPort: 170,714 shares worth $7.49M.
  • Moody Aldrich Partners added most to Evercore in Q4 2020, an estimated $4.92M increase.
  • Moody Aldrich Partners's biggest Q4 2020 reduction was Walker & Dunlop, cutting an estimated $3.49M.
  • Moody Aldrich Partners fully exited Chesapeake Utilities in Q4 2020, selling an estimated $6.77M.
  • Moody Aldrich Partners's ten largest holdings make up 18% of its $620M portfolio in Q4 2020.
  • Moody Aldrich Partners opened 37 new positions and closed 17 in Q4 2020.
  • Moody Aldrich Partners's portfolio value rose 30% quarter-over-quarter to $620M.

Based on Moody Aldrich Partners's 13F filing for Q4 2020, filed 16 Feb 2021.